Drug Class
monoclonal antibody targeting CD38
Type
brand
Active Ingredient
daratumumab
📋Overview
Darzalex is a monoclonal antibody medication primarily used in the management of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. It works by targeting a specific protein found on the surface of these cancerous cells, helping the immune system recognize and attack them. Darzalex is often associated with use in patients who have received prior therapies for their condition. Its introduction has expanded the options available for treating certain blood cancers.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Darzalex
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.